Related Articles
Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells
Effects of dihydroartemisinin on the gut microbiome of mice
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway
Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis
Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation